Potential of 3’-fluoro-3’ deoxythymidine as a cellular proliferation marker in PET oncology examination

Potential of 3’-fluoro-3’ deoxythymidine as a cellular proliferation marker in PET oncology examination

Show other versions (1)

Development of the positron emission tomography (PET) diagnostic radiopharmaceutical (18F) fluoro-2-deoxy-D-glucose (18F-FDG) subsequently facilitated the discovery and clinical evaluation of several new tracers as imaging markers for cancer. While 18F-FDG is a widely employed marker for enhanced in...

Full description

Bibliographic Details
Main Authors:	Hassan, Hishar, Price, Roger, Ahmad Saad, Fathinul Fikri, Lau, Eddie Wing Fai, Carpinelli, Assunta, Nordin, Abdul Jalil
Format:	Article
Language:	English
Published:	Universiti Putra Malaysia Press 2016
Online Access:	http://psasir.upm.edu.my/id/eprint/29519/1/03%20JST-0544-2015%20Rev1-%20Hishar%20Hassanr-Review%20Paper.pdf

Similar Items

Potential of 3'-fluoro-3' deoxythymidine as a cellular proliferation marker in PET oncology examination
by: Hassan, Hishar, et al.
Published: (2016)

Dose optimisation of 18F-flurodeoxyglucose for whole body PET oncology examination in CDNI of UPM
by: Hassan, Hishar, et al.
Published: (2015)

Impact of Anesthetics on 3′-[F]Fluoro-3′-Deoxythymidine ([F]FLT) Uptake in Animal Models of Cancer and Inflammation
by: Kerstin Fuchs, et al.
Published: (2013-07-01)

Impact of total activity variation in 18F-FDG injected with the overall PET image quality in oncology patients
by: Hassan, Muhammad Hishar, et al.
Published: (2012)

Applications of 18(F) FDG PET/CT in oncology
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2015)

18F FDG PET-CT in oncology & interesting images
by: Ahmad Saad, Fathinul Fikri
Published: (2015)

Avid 18F-FDG uptake of pectoralis major muscle: an equivocal sequela of strenuous physical exercise
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2009)

18[F] FDG-PET/CT is a useful molecular marker in evaluating thymoma aggressiveness.
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2011)

Synthesis of new 3'-N-alcyl and 3'-N-alkyl 3'-amino-3'-deoxythymidine derivatives
by: K. V. Seregin, et al.
Published: (2006-02-01)

3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumor
by: James L. Tatum, et al.
Published: (2022-08-01)

Potential of 82Rb PET-CT as an angiogenesis marker in evaluating tumour aggressiveness
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2013)

18[F]FDG-PET/CT is a useful molecular marker in evaluating tumour aggressiveness: a revised understanding of an in-vivo FDG-PET imaging that alludes the alteration of cancer biology
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2013)

METHYL 5-O-TERT-BUTYLDIPHENYLSILYL-2-DEOXY-ALPHA,BETA-D-THREO-PENTOFURANOSIDE AS A DIVERGENT INTERMEDIATE FOR THE SYNTHESIS OF 3'-SUBSTITUTED-2',3'-DIDEOXYNUCLEOSIDES - SYNTHESIS OF 3'-AZIDO-3'-DEOXYTHYMIDINE, 3'-DEOXY-3'-FLUOROTHYMIDINE AND 3'-CYANO-3'-DEOXYTHYMIDINE
by: Fleet, G, et al.
Published: (1988)

18F-FDG PET/CT as a potential valuable adjunct to MRI in characterising the Brodie's abscess
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2010)

18F-FDG PET/CT as a potential valuable adjunct to MRI in characterising the Brodies abscess
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2010)

An intense 18F-FDG pulmonary microfocus on PET without detectable abnormality on CT: a manifestation of an iatrogenic FDG pulmonary embolus
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2010)

Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2014)

2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine
by: M. Matilde Marques, et al.
Published: (2013-04-01)

Pattern of calcification on CT and FDG-PET of a rare perineural mantle cell lymphoma: a potential of non-histological imaging marker
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2016)

3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.
by: Ren, J, et al.
Published: (1998)

The association of FDG-PET (SUVmax) and inflammatory marker in predicting tumour aggressiveness
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2018)

Molecular imaging.
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2013)

18F-FDG-PET CT features of colo-colic intussusceptions in patient with colonic carcinoma
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2016)

18F-FDG PET/CT as a potential predictor of survival in patient with oesophageal cancer: a preliminary result
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2015)

Significance of subcentimetre 18F-FDG PET/CT pulmonary abnormality in patients with known extrapulmonary malignancy.
by: Ahmad Saad , Fathinul Fikri, et al.
Published: (2010)

Impact of prolonged reduced-pressure condition prior to precursor labeling on the labeling efficiency of F-18 fluorocholine synthesis
by: Hassan, Hishar, et al.
Published: (2018)

?-Fluoro-Benzylphosphonates as Reagents for the Preparation of 1-Fluoro-1-Aryl Alkenes and ?-Fluorostilbenes
by: Thomas Allmendinger, et al.
Published: (2004-03-01)

Perirectal metachronous recurrence of the hepatocellular carcinoma in the rectum on the 11C choline PET–CT
by: Fathinul Fikri, A.S, et al.
Published: (2021)

The value of 18F-fluorodeoxyglucose-positron emission tomography/ computed tomography (18F- FDG PET/CT) in the staging and impact on the management of patients with nasopharyngeal carcinoma
by: Subha, Sethu Thakachy, et al.
Published: (2017)

Biocatalytic synthesis of 2-fluoro-3-hydroxypropionic acid
by: Wei Liu, et al.
Published: (2022-08-01)

Estimation of patient radiation dose from whole body 18F-FDG PET/CT examination in cancer imaging: a preliminary study
by: Mahmud, Mohd Hafizi, et al.
Published: (2014)

Insight into the Development of PET Radiopharmaceuticals for Oncology
by: Joseph Lau, et al.
Published: (2020-05-01)

METHYL 5-O-TERT-BUTYLDIPHENYLSILYL-2-DEOXY-D-THREO-PENTOFURANOSIDE - AN APPROACH TO THE SYNTHESIS OF 3'-SUBSTITUTED-2',3'-DIDEOXYNUCLEOSIDES INCLUDING 3'-AZIDO-3'-DEOXYTHYMIDINE AND OF 3'-SUBSTITUTED-2',3'-DIDEOXY-C-NUCLEOSIDES
by: Fleet, G, et al.
Published: (1987)

3′-[4-({[3β,28-Bis(acetyloxy)lup-20(29)-en-30-yl]oxy}carbonyl)-1<i>H</i>-1,2,3-triazol-1-yl]-3′-deoxythymidine
by: Ewa Bębenek, et al.
Published: (2022-05-01)

Mapping 18F-fluorodeoxyglucose metabolism using PET/CT for the assessment of treatment response in non-small cell lung cancer patients undergoing epidermal growth factor receptor inhibitor treatment: a single-centre experience
by: Suppiah, Subapriya, et al.
Published: (2017)

Combined ultrasound and IVU for the management of childhood urolithiasis: a case report
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2012)

5-Fluoro-3-(1H-indol-3-ylmethyl)-1H-indole
by: Guozhe Guo
Published: (2023-08-01)

Radiation dose to radiosensitive organs in PET/CT myocardial perfusion examination using versatile optical fibre
by: Salasiah, M., et al.
Published: (2013)

Clinical applications of the standard uptake values of the contrasted 18[F]FDG-PET/CT in nasopharyngeal carcinoma patients.
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2011)

5-Fluoro-2-(2-fluorophenyl)-3-methylsulfinyl-1-benzofuran
by: Hong Dae Choi, et al.
Published: (2014-07-01)